Open access · CC-BY
via OpenAlex
Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration
Robyn A. Honea, Carlos Cruchaga, Rodrigo Dennis Perea, Andrew J. Saykin, Jeffrey Murray Burns, Daniel R. Weinberger, Alison Goate, Alzheimer’s Disease Neuroimaging Initiative
PLoS ONE · 2013 · ▲ 58 citations
Abstract
There is accumulating evidence that neurotrophins, like brain-derived neurotrophic factor (BDNF), may impact aging and Alzheimer's Disease. However, traditional genetic association studies have not found a clear relationship between BDNF and AD. Our goal was to test whether BDNF single nucleotide polymorphisms (SNPs) impact Alzheimer's Disease-related brain imaging and cognitive markers of disease. We completed an imaging genetics study on 645 Alzheimer's Disease Neuroimaging Initiative participants (ND=175, MCI=316, AD=154) who had cognitive, brain imaging, and genetics data at baseline and a subset of those with brain imaging data at two years. Samples were genotyped using the Illumina Human610-Quad BeadChip. 13 SNPs in BDNF were identified in the dataset following quality control measures (rs6265(Val66Met), rs12273363, rs11030094, rs925946, rs1050187, rs2203877, rs11030104, rs11030108, rs10835211, rs7934165, rs908867, rs1491850, rs1157459). We analyzed a subgroup of 8 SNPs that were in low linkage disequilibrium with each other. Automated brain morphometric measures were available through ADNI investigators, and we analyzed baseline cognitive scores, hippocampal and whole brain volumes, and rates of hippocampal and whole brain atrophy and rates of change in the ADAS-Cog over one and two years. Three out of eight BDNF SNPs analyzed were significantly associated with measures of cognitive decline (rs1157659, rs11030094, rs11030108). No SNPs were significantly associated with baseline brain volume measures, however six SNPs were significantly associated with hippocampal and/or whole brain atrophy over two years (rs908867, rs11030094, rs6265, rs10501087, rs1157659, rs1491850). We also found an interaction between the BDNF Val66Met SNP and age with whole brain volume. Our imaging-genetics analysis in a large dataset suggests that while BDNF genetic variation is not specifically associated with a diagnosis of AD, it appears to play a role in AD-related brain neurodegeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0076001
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Honea, R.A., Cruchaga, C., Perea, R.D., Saykin, A.J., Burns, J.M., Weinberger, D.R., Goate, A., & Initiative, A.D.N. (2013). Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0076001
Vancouver
Honea RA, Cruchaga C, Perea RD, Saykin AJ, Burns JM, Weinberger DR, et al. Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration. PLoS ONE. 2013. doi:10.1371/journal.pone.0076001.
BibTeX
@article{robyn2013Charac,
title = {Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration},
author = {Robyn A. Honea and Carlos Cruchaga and Rodrigo Dennis Perea and Andrew J. Saykin and Jeffrey Murray Burns and Daniel R. Weinberger and Alison Goate and Alzheimer’s Disease Neuroimaging Initiative},
journal = {PLoS ONE},
year = {2013},
doi = {10.1371/journal.pone.0076001},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2014
Citation only
Effects of genetic variation on the dynamics of neurodegeneration in Alzheimer's disease
Movement Disorders 2014
Open access · OA
Alpha‐synuclein repeat variants and survival in Parkinson's disease
npj Aging 2026
Open access · CC-BY
Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment
npj aging 2026
Open access · OA
Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment.
H. Lundbeck A/S 2005
Open access · US-GOV
A 1-year Randomised, Double-blind Placebo-controlled Study to Evaluate the Effects of Memantine on Rate of Brain Atrophy in Patients With Alzheimer's Disease
Experimental Gerontology 2024
Open access · CC-BY